Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,324 papers from all fields of science
Search
Sign In
Create Free Account
Esophageal neoplasm metastatic
Known as:
metastatic esophageal cancer
, esophageal cancer, metastatic
, Stage IV Esophageal Cancer
Expand
Stage IV includes: For squamous cell carcinoma: Any T, Any N, M1, Any G, Tumor location: Any. For adenocarcinoma: Any T, Any N, M1, Any G. M1…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Epithelial Cells
Epithelium
Epithelium of esophagus
Esophagus
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Clinical Observation of Bevacizumab Combined with S-1 in the Treatment of Pretreated Advanced Esophageal Carcinoma.
Keke Nie
,
Chuan-xin Geng
,
+5 authors
Youxin Ji
Chinese medical sciences journal = Chung-kuo i…
2016
Corpus ID: 23081820
Highly Cited
2010
Highly Cited
2010
Cetuximab as Second-Line Therapy in Patients with Metastatic Esophageal Adenocarcinoma: A Phase II Southwest Oncology Group Study (S0415)
P. Gold
,
B. Goldman
,
+4 authors
C. Blanke
Journal of Thoracic Oncology
2010
Corpus ID: 9633839
Introduction: Esophageal adenocarcinomas commonly express the epidermal growth factor receptor. This trial assessed the 6-month…
Expand
2010
2010
Predictors of Failure of the Laparoscopic Approach for the Management of Small Bowel Obstruction
I. Qureshi
,
Z. Awad
The American surgeon
2010
Corpus ID: 19788583
Small bowel obstruction (SBO) is a common cause of hospital admission. Our objective is to determine variables that correlate…
Expand
2008
2008
Cetuximab as second-line therapy in patients with metastatic esophageal cancer: A phase II Southwest Oncology Group Study
P. Gold
,
B. Goldman
,
S. Iqbal
,
L. Leichman
,
H. Lenz
,
C. Blanke
2008
Corpus ID: 74644359
4536 Background: Survival for patients (pts) with metastatic esophageal cancer is poor, with no established therapy for patients…
Expand
2007
2007
Second-Line Combination Chemotherapy with Docetaxel for Cisplatin-Pretreated Refractory Metastatic Esophageal Cancer: A Preliminary Report of Initial Experience
Toshiaki Tanaka
,
H. Fujita
,
+6 authors
K. Shirouzu
Chemotherapy
2007
Corpus ID: 22668475
Background and Aims: Patients with esophageal cancer often develop metastatic disease after esophageal resection and generally…
Expand
2007
2007
Metastatic esophageal tumor from cecal carcinoma.
H. Kagaya
,
J. Kitayama
,
+5 authors
H. Nagawa
Japanese Journal of Clinical Oncology
2007
Corpus ID: 7631963
A 55-year-old man developed progressive dysphagia 14 months after palliative colectomy and subsequent systemic chemotherapy for…
Expand
2003
2003
Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy
H. Iwase
,
M. Shimada
,
+7 authors
K. Kusugami
International Journal of Clinical Oncology
2003
Corpus ID: 9425528
AbstractBackground. No effective treatment for advanced esophageal cancer extending to adjacent organs or associated with distant…
Expand
2003
2003
Phase II Trial of 96-Hour Paclitaxel in Previously Treated Patients with Advanced Esophageal Cancer
S. Anderson
,
E. O’Reilly
,
D. Kelsen
,
D. Ilson
Cancer Investigation
2003
Corpus ID: 21789804
Background. A 96-hour infusion schedule of paclitaxel demonstrates tolerability and antitumor activity in lung cancer and breast…
Expand
2003
2003
Phase II study of docetaxel and irinotecan in metastatic or recurrent esophageal cancer: a preliminary report.
R. Govindan
,
W. Read
,
+5 authors
M. Perry
Oncology
2003
Corpus ID: 30235507
The outcomes for patients with metastatic or recurrent esophageal cancer are dismal, with 1-year survival rates of approximately…
Expand
1999
1999
Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.
C. Blanke
,
H. Choy
,
+5 authors
D. Johnson
Seminars in Radiation Oncology
1999
Corpus ID: 10642405
Esophageal cancer is a major cause of morbidity and mortality worldwide. Although patients often present with apparently…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE